Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-24

Clinical Trial Update: A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating placenta-derived decidual stromal cells for hemorrhagic cystitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Placenta-Derived Decidual Stromal Cells (decidual stromal cells)

Snippet

Sponsor: Karolinska Institutet | Conditions: Hemorrhagic Cystitis | Phase 1, Phase 2 | Status: COMPLETED